Exponent Declares Regular Quarterly Dividend for Q4 2025 and Increases Stock Repurchase Authorization by $100 Million
Exponent (Nasdaq: EXPO) declared a quarterly cash dividend of $0.30 per share, payable on December 19, 2025 to stockholders of record as of December 5, 2025. The company expects to continue quarterly dividends in March, June, September, and December, subject to Board approval.
Separately, the Board increased the share repurchase authorization by $100 million, adding to the $21.6 million available for repurchase as of October 3, 2025. Management cited strong cash flow and balance sheet strength as the rationale for these capital-allocation actions.
Exponent (Nasdaq: EXPO) ha dichiarato un dividendo cash trimestrale di $0.30 per azione, pagabile il 19 dicembre 2025 agli azionisti registrati al 5 dicembre 2025. L'azienda prevede di continuare i dividendi trimestrali in marzo, giugno, settembre e dicembre, soggetti all'approvazione del Consiglio. Separatamente, il Consiglio ha aumentato l'autorizzazione per il riacquisto di azioni di $100 milioni, aggiungendosi ai $21.6 milioni disponibili al riacquisto al 3 ottobre 2025. La direzione ha citato un forte flusso di cassa e solidità del bilancio come motivazione per queste azioni di allocazione del capitale.
Exponent (Nasdaq: EXPO) declaró un dividendo en efectivo trimestral de $0.30 por acción, pagadero el 19 de diciembre de 2025 a los accionistas registrados a 5 de diciembre de 2025. La empresa espera continuar con dividendos trimestrales en marzo, junio, septiembre y diciembre, sujeto a la aprobación de la Junta. Separadamente, la Junta aumentó la autorización de recompra de acciones en $100 millones, sumando a los $21.6 millones disponibles para recompra a partir de 3 de octubre de 2025. La dirección citó un flujo de caja sólido y la fortaleza del balance como la razón de estas acciones de asignación de capital.
Exponent (Nasdaq: EXPO)는 주당 $0.30의 분기별 현금 배당을 선언했으며, 이는 2025년 12월 19일에 지급되고 2025년 12월 5일 기준으로 등록된 주주들에게 지급됩니다. 회사는 이사회 승인을 조건으로 3월, 6월, 9월, 12월에 분기별 배당을 계속할 것으로 기대합니다. 한편 이사회는 주식 매입 허가를 $100백만으로 늘렸으며, 2025년 10월 3일 기준으로 사용 가능한 $21.6백만에 더해졌습니다. 경영진은 강한 현금 흐름과 재무 상태의 강점을 이러한 자본 배분 조치의 근거로 들었습니다.
Exponent (Nasdaq: EXPO) a annoncé un dividende en espèces trimestriel de 0,30 $ par action, payable le 19 décembre 2025 aux actionnaires enregistrés au 5 décembre 2025. La société prévoit de poursuivre les dividendes trimestriels en mars, juin, septembre et décembre, sous réserve de l'approbation du conseil d'administration. Par ailleurs, le conseil a augmenté l'autorisation de rachat d'actions de 100 millions de dollars, en ajout aux 21,6 millions de dollars disponibles pour le rachat au 3 octobre 2025. La direction a cité un flux de trésorerie solide et la robustesse du bilan comme justification de ces actions d'allocation de capital.
Exponent (Nasdaq: EXPO) kündigte eine vierteljährliche Barausschüttung von $0.30 pro Aktie an, zahlbar am 19. Dezember 2025 an Aktieninhaber mit dem Stichtag 5. Dezember 2025. Das Unternehmen erwartet, die vierteljährlichen Dividenden im März, Juni, September und Dezember fortzusetzen, vorbehaltlich der Zustimmung des Vorstands. Separat hat der Vorstand die Rückkaufbefugung für Aktien um $100 Millionen erhöht, zusätzlich zu den $21.6 Millionen, die zum Rückkauf am 3. Oktober 2025 verfügbar waren. Das Management verwies auf starken Cashflow und die Bilanzstärke als Begründung für diese Kapitalallokationsmaßnahmen.
Exponent (Nasdaq: EXPO) أعلنت عن توزيع نقدي ربعي قدره 0.30 دولار للسهم، يُدفع للمساهمين المسجلين حتى 19 ديسمبر 2025، والذين لهم سجل حتى 5 ديسمبر 2025. تتوقع الشركة الاستمرار في توزيعات الأرباح الربعية في مارس ويونيو وسبتمبر وديسمبر، بشرط موافقة المجلس. منفصلًا، عزّز المجلس تفويض إعادة شراء الأسهم بمقدار 100 مليون دولار، ليضاف إلى 21.6 مليون دولار المتاحة لإعادة الشراء اعتبارًا من 3 أكتوبر 2025. وأشارت الإدارة إلى وجود تدفق نقدي قوي وقوة الميزانية كمبررات لهذه الإجراءات في تخصيص رأس المال.
- Dividend declared of $0.30 per common share
- Payment date set for December 19, 2025
- Record date established as December 5, 2025
- Repurchase authorization increased by $100 million
- Existing repurchase available was $21.6 million as of Oct 3, 2025
- Dividend continuation is subject to final Board determination
MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of
Exponent has paid, and expects to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.
In addition, Exponent’s Board of Directors increased the Company’s authority to repurchase shares of its common stock by
“Today’s actions reflect the Board’s confidence in our strategy, strong cash flow generation, and commitment to delivering long-term value to our shareholders,” commented Dr. Catherine Corrigan, President and Chief Executive Officer. “The combination of a consistent dividend and an increased share repurchase authorization underscores the strength of our balance sheet and our disciplined approach to capital allocation.”
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.
Forward Looking Statements
This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
FAQ
What dividend did Exponent (EXPO) declare for Q4 2025?
When will Exponent (EXPO) pay the Q4 2025 dividend?
How much did Exponent (EXPO) increase its share repurchase authorization by on Oct 30, 2025?
How much repurchase capacity did Exponent (EXPO) have before the $100 million increase?
Are Exponent's future dividends guaranteed after the Q4 2025 declaration?
